These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 19348604)

  • 1. Microporation applications for enhancing drug delivery.
    Banga AK
    Expert Opin Drug Deliv; 2009 Apr; 6(4):343-54. PubMed ID: 19348604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microneedles for transdermal drug delivery.
    Prausnitz MR
    Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in microneedle-based drug delivery: Special emphasis on its use in paediatric population.
    Duarah S; Sharma M; Wen J
    Eur J Pharm Biopharm; 2019 Mar; 136():48-69. PubMed ID: 30633972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microneedles and transdermal applications.
    Sivamani RK; Liepmann D; Maibach HI
    Expert Opin Drug Deliv; 2007 Jan; 4(1):19-25. PubMed ID: 17184159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations in the use of microneedles: pain, convenience, anxiety and safety.
    Jeong HR; Lee HS; Choi IJ; Park JH
    J Drug Target; 2017 Jan; 25(1):29-40. PubMed ID: 27282644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
    Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
    Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microneedles: an emerging transdermal drug delivery system.
    Bariya SH; Gohel MC; Mehta TA; Sharma OP
    J Pharm Pharmacol; 2012 Jan; 64(1):11-29. PubMed ID: 22150668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of patents for microneedle application devices allowing fluid injections through the skin.
    Lhernould MS; Tailler S; Deleers M; Delchambre A
    Recent Pat Drug Deliv Formul; 2015; 9(2):146-57. PubMed ID: 25770583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing microneedle arrays for transdermal drug delivery: extension to non-square distribution of microneedles.
    Al-Qallaf B; Das DB
    J Drug Target; 2009 Feb; 17(2):108-22. PubMed ID: 19016071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microneedles and their applications.
    Sachdeva V; Banga AK
    Recent Pat Drug Deliv Formul; 2011 May; 5(2):95-132. PubMed ID: 21453248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterial and advanced technologies in transdermal drug delivery.
    Rabiei M; Kashanian S; Samavati SS; Jamasb S; McInnes SJP
    J Drug Target; 2020 Apr; 28(4):356-367. PubMed ID: 31851847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple method of microneedle array fabrication for transdermal drug delivery.
    Kochhar JS; Goh WJ; Chan SY; Kang L
    Drug Dev Ind Pharm; 2013 Feb; 39(2):299-309. PubMed ID: 22519721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current advances in the fabrication of microneedles for transdermal delivery.
    Indermun S; Luttge R; Choonara YE; Kumar P; du Toit LC; Modi G; Pillay V
    J Control Release; 2014 Jul; 185():130-8. PubMed ID: 24806483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controllable coating of microneedles for transdermal drug delivery.
    Chen J; Qiu Y; Zhang S; Yang G; Gao Y
    Drug Dev Ind Pharm; 2015 Mar; 41(3):415-22. PubMed ID: 24378200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview on the advantages and limitations of 3D printing of microneedles.
    Ozyilmaz ED; Turan A; Comoglu T
    Pharm Dev Technol; 2021 Nov; 26(9):923-933. PubMed ID: 34369288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations.
    Kirkby M; Hutton ARJ; Donnelly RF
    Pharm Res; 2020 Jun; 37(6):117. PubMed ID: 32488611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication, characterization and application of sugar microneedles for transdermal drug delivery.
    Nguyen HX; Banga AK
    Ther Deliv; 2017 Mar; 8(5):249-264. PubMed ID: 28361607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration.
    McGrath MG; Vucen S; Vrdoljak A; Kelly A; O'Mahony C; Crean AM; Moore A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):200-11. PubMed ID: 23727511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coated microneedles for transdermal delivery.
    Gill HS; Prausnitz MR
    J Control Release; 2007 Feb; 117(2):227-37. PubMed ID: 17169459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microneedles: A New Frontier in Nanomedicine Delivery.
    Larrañeta E; McCrudden MT; Courtenay AJ; Donnelly RF
    Pharm Res; 2016 May; 33(5):1055-73. PubMed ID: 26908048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.